- Home
- KIDS vs VALN Comparison
KIDS vs VALN Comparison
Compare KIDS & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- VALN
- Stock Information
- Founded
- KIDS 2007
- VALN 2012
- Country
- KIDS United States
- VALN France
- Employees
- KIDS N/A
- VALN N/A
- Industry
- KIDS Medical/Dental Instruments
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KIDS Health Care
- VALN Health Care
- Exchange
- KIDS Nasdaq
- VALN Nasdaq
- Market Cap
- KIDS 601.5M
- VALN 510.7M
- IPO Year
- KIDS 2017
- VALN 2021
- Fundamental
- Price
- KIDS $22.04
- VALN $6.36
- Analyst Decision
- KIDS Buy
- VALN Strong Buy
- Analyst Count
- KIDS 7
- VALN 3
- Target Price
- KIDS $35.71
- VALN $15.33
- AVG Volume (30 Days)
- KIDS 133.8K
- VALN 14.9K
- Earning Date
- KIDS 05-07-2025
- VALN 05-07-2025
- Dividend Yield
- KIDS N/A
- VALN N/A
- EPS Growth
- KIDS N/A
- VALN N/A
- EPS
- KIDS N/A
- VALN N/A
- Revenue
- KIDS $212,453,000.00
- VALN $201,099,222.00
- Revenue This Year
- KIDS $18.99
- VALN $17.98
- Revenue Next Year
- KIDS $17.04
- VALN $26.61
- P/E Ratio
- KIDS N/A
- VALN N/A
- Revenue Growth
- KIDS 31.28
- VALN 21.64
- 52 Week Low
- KIDS $20.25
- VALN $3.62
- 52 Week High
- KIDS $35.99
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- KIDS 49.93
- VALN 46.37
- Support Level
- KIDS $20.69
- VALN $6.25
- Resistance Level
- KIDS $23.63
- VALN $6.65
- Average True Range (ATR)
- KIDS 1.13
- VALN 0.30
- MACD
- KIDS 0.27
- VALN -0.02
- Stochastic Oscillator
- KIDS 53.00
- VALN 27.24
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.